Cargando…
Comorbid psoriasis-bipolar disorder successfully treated with apremilast: much more than a mere coincidence?
Psoriasis is a chronic, immune mediated, systemic inflammatory skin disease with a reported prevalence of 0.6%–4.8% in the general population. Bipolar disorder (BP) is a severe episodic psychiatric disorder that ranks as the fourth leading cause of disability. Recent evidence suggests that genetic a...
Autores principales: | Uvais, N A, Rakhesh, S V, Afra, T P, Hafi, N A Bishurul, Razmi T, Muhammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245448/ https://www.ncbi.nlm.nih.gov/pubmed/32524074 http://dx.doi.org/10.1136/gpsych-2019-100181 |
Ejemplares similares
-
Comorbid Bipolar Disorder and Benign Joint Hyper Mobility Syndrome (BJHS): More than a Mere Coincidence?
por: Uvais, N. A., et al.
Publicado: (2019) -
Apremilast in Psoriasis and Beyond: Big Hopes on a Small Molecule
por: Afra, T. P., et al.
Publicado: (2019) -
Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?
por: Afra, TP, et al.
Publicado: (2020) -
Linking hydroxychloroquine to hemolysis in a ‘suspected’ glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection – a critical appraisal
por: Afra, T.P., et al.
Publicado: (2020) -
Palliative Dermatology
por: Bishurul Hafi, NA, et al.
Publicado: (2018)